Start of New PG Medical courses, increase intake: NMC Notifies Final Decision on 301 Applications from 66 Medical Institutes
National Medical Commission Posts Lying Vacant
New Delhi: The Medical Assessment and Rating Board (MARB) of the National Medical Commission (NMC) has notified its final decision on 301 more applications for starting new postgraduate medical courses or an increase of PG medical seats in the existing courses.
Issuing a notice on 21st June 2024, the Commission released a list of these applications received from altogether 66 medical institutes. The Commission also informed that it has communicated its decision to these medical institutes through e-mail for information and necessary action by them within the stipulated timeline.
Among these 301 applications, 168 applications were for starting of new PG Medical Courses and 133 applications were for an increase of seats in PG Medical courses.
"In continuation of MARB’s Public Notice dated the 28th April 2024, with reference to applications from medical institutions for start or increase of PG medical courses/seats, it is informed that final decision of MARB in respect of 301 more applications (for starting of new PG Medical courses and increase of seats in PG Medical courses for the Academic year: 2024-25) has been communicated through e-mail IDs (as mentioned in online applications) to the Medical Institutions/Colleges concerned for information and necessary action by them within the stipulated timeline," the NMC notice dated 21.06.2024 stated.
"A list containing application number of each of the aforesaid 301 applications (168 applications for starting of new PG Medical courses and 133 applications for increase of seats in PG Medical courses) is attached with this public notice for general information," it added.
Medical Dialogues had earlier reported that through a notice dated 28.04.2024, NMC had sent its final decision to 18 medical colleges in respect of 101 applications for the starting of new PG medical courses and an increase of seats for the academic year 2024-2025. At that time, the Commission had informed that communications of the final decision in respect of remaining applications would be sent in due course.
Again on 04.05.2024, NMC issued another notice and communicated its final decision to 31 medical institutes in respect of 153 applications. In the last month, NMC issued more communications and notified its final decisions on several other applications. Recently, through a notice dated 03.06.2024, NMC notified its decision on 117 more applications to start or increase PG medical seats. Again on 12.06.2024, NMC notified its decision on 156 more applications.
Referring to these earlier communications, NMC mentioned in the notice dated 21.06.2024, "It may be recalled that vide MARB’s Public notice of even number dated the 28th April 2024, 4th May 2024, 10th May 2024, 18th May 2024 21st May 2024, 30th May 2024, 3rd June 2024 & 12th June 2024 it was informed that final decision in respect of 1077 online PG Medical course applications (806 applications for starting of new PG Medical courses and 271 applications for increase of seats in PG Medical courses) had already been communicated through the email IDs (as mentioned in online applications) to the Medical Institutions/Colleges concerned."
"Final decision in respect of remaining applications received online will be sent in due course. This issues with the approval of the Competent Authority," it added.
To view the NMC notice, click on the link below:
https://medicaldialogues.in/pdf_upload/nmc-notice-21062024-241735.pdf
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.